Accenture and Wharton mapped AI's impact across 18 industries, concluding: the smarter your agents get, the more ...
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today reported its business update and ...
Lacutamab TELLOMAK-3 confirmatory Phase 3 trial in cutaneous T-cell lymphoma (CTCL) is planned for initiation in H2 2026, subject to non-dilutive financing options currently under negotiation, includi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results